Alternatives to Isomorphic Labs

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

AI-driven lab automation for biological research and discovery at scale.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Life science company pioneering drug discovery with AI and advanced technologies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI platform for accelerating novel peptide therapeutic discovery and development.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Vivodyne is developing advanced AI models for drug discovery and development.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

AI-powered platform accelerating biological research and drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops a computational model of the human body for drug discovery and development.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-guided drug discovery platform for tissue-targeted medicines.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-powered research assistant for scientific literature review and data extraction.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

AI-powered platform for designing novel molecular structures for new medicines.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

A global leader in clinical pharmacology and bioanalytical sciences.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Selitectix develops AI-powered solutions for drug discovery, focusing on accelerating the identification and optimization of novel therapeutic candidates.

Develops a platform for adaptive clinical trial design and closed-loop execution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-driven platform for protein-level disease mapping and drug discovery.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered knowledge discovery for life sciences.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

AI-powered email management and scientific research platforms.